Orange Book Blog

At the intersection of Patent and FDA Law

Recent Posts

Month: May 2007

  • Pharma News Briefs

    AP published this report on yesterday’s House hearing on "reverse payment" settlements. AP also recently published this article on follow-on biologics legislation, entitled "Time is Running Out for Generic Biotech." Antitrust Review recently posted an update on the FTC’s authorized generics study. FDA Law Blog has a new post today on the most recent developments…

  • House Energy and Commerce Committee to Hold Hearings on Follow-on Biologics and Reverse Payments

    On Wednesday, May 2nd, two subcommittees of the House Committee on Energy and Commerce will hold hearings of importance to pharmaceutical companies: first, on legislation to establish an abbreviated pathway for FDA approval of follow-on biologics; second, on a pending bill to ban “reverse payment” settlements of Hatch-Waxman litigation. At 10 a.m. ET, the Subcommittee…

  • ACI “FDA Boot Camp” Conference, May 15-16, San Francisco

    American Conference Institute is planning another “FDA Boot Camp” conference for May 15-16 in San Francisco.  Prior versions of this conference in New York and Chicago were very popular. According to ACI, “FDA Boot Camp has been designed to give product or patent litigators, as well as patent prosecutors and life sciences investment and securities experts, a strong working…